ECRM_1170x120_8-1-17

Gary Downing

CHPA welcomes new board members

CHPA welcomes new board members

WASHINGTON — New members of the Consumer Healthcare Products Association (CHPA) board of directors were elected at the association’s fall meeting, held November 14, in New York City. Gary Downing, chief executive officer, Clarion Brands, continues serving as CHPA’s board chairman. Newly elected CHPA board members at this meeting include: Paul Gama, vice president, North America

CHPA bullish on pending revision of O-T-C monograph policy

CHPA bullish on pending revision of O-T-C monograph policy

WASHINGTON — The stage is set for a regulatory change that will boost innovation by consumer health care products manufacturers, according to leaders of their association. The Food and Drug Administration’s O-T-C monograph system, which hasn’t been updated for over 45 years, is facing massive modernization efforts in the form of pending legislation in both

Retail evolution bodes well for nonprescription meds

Retail evolution bodes well for nonprescription meds

WASHINGTON — Changes on the retail scene bode well for the consumer health care products market because they show that chains are trying to stay engaged with their customers, says Consumer Healthcare Products Association (CHPA) chairman and Clarion Brands chief executive officer Gary Downing. “From our perspective it would be more concerning if they were

Clarion Brands acquires Florajen probiotics

Clarion Brands acquires Florajen probiotics

TREVOSE, Pa. — Clarion Brands has expanded its over-the-counter health product lineup with the acquisition of the Florajen probiotic brand. Financial terms of the deal weren’t disclosed. Clarion said Tuesday that the purchase of Florajen, marketed by American Lifeline Inc., now gives it three No. 1 professionally recommended brands. Florajen is billed as the No.